HAPLN1 is a driver for peritoneal carcinomatosis in pancreatic cancer
L. Wiedmann, F. De Angelis Rigotti, N. Vaquero-Siguero, E. Donato, E. Espinet, I. Moll, E. Alsina-Sanchis, R. Mülfarth, M. Vacca, J. Gerwing, A. Trumpp, A. Fischer, J. Rodriguez-Vita
This study identifies HAPLN1 as a driver of peritoneal metastasis in pancreatic cancer by enhancing tumor cell plasticity and immunomodulation.
bioRxiv · May 30, 2022Cancer Biology